Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis

被引:38
|
作者
Chasset, Francois [1 ]
Frances, Camille [1 ]
机构
[1] Univ Pierre & Marie Curie Paris VI, Hop Tenon, AP HP, Serv Dermatol Allergol, 4 Rue Chine, F-75020 Paris, France
关键词
Takayasu arteritis; Giant-cell arteritis; Polyarteritis nodosa; Kawasaki disease; GIANT-CELL ARTERITIS; SYSTEMIC-NECROTIZING-VASCULITIDES; PLACEBO-CONTROLLED TRIAL; OF-THE-LITERATURE; POLYARTERITIS-NODOSA; TAKAYASU ARTERITIS; KAWASAKI-DISEASE; DOUBLE-BLIND; DIAGNOSTIC-CRITERIA; SCALP NECROSIS;
D O I
10.1007/s12016-017-8612-9
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Dermatologic manifestations are observed in almost all systemic vasculitides, even in large-and medium-vessel vasculitides, although such vessels are not found in the skin. Cutaneous manifestations may be related to a direct skin localization of the systemic vasculitis or a non-specific process associated with the vasculitis. According to the 2012 International Chapel Hill consensus, the two major variants of large-vessel vasculitides are Takayasu arteritis and giant-cell arteritis. In Europe and North America, acute inflammatory nodules or erythema nodosum-like lesions are the most commonly observed skin lesions with Takayasu arteritis. Medium-sized arteriole vasculitis of the dermis or subcutis but also septal or lobular panniculitis may be found during pathological examination. In Japan, widespread pyoderma gangrenosum-like lesions are more frequent. Cutaneous manifestations of giant-cell arteritis are rare; they are ischemic, linked to arterial occlusions, or non-ischemic, with various mechanisms. The two major medium-vessel vasculitides are Kawasaki disease and polyarteritis nodosa. Kawasaki disease is characterized by a mucocutaneous lymph node syndrome without skin vasculitis. Two subsets of polyarteritis nodosa with different skin manifestations are described, without transition from one to the other. In the systemic subset, the most frequent skin lesions are in the order of frequency purpura, livedo, and nodules. Cutaneous polyarteritis nodosa mainly features nodules, livedo racemosa, and ulcerations. Genetic screening and measurement of plasma levels of adenosine deaminase 2 should be considered for patients with uncommon systemic polyarteritis nodosa or early-onset cutaneous polyarteritis nodosa.
引用
收藏
页码:452 / 468
页数:17
相关论文
共 50 条
  • [1] Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis
    Francois Chasset
    Camille Francès
    Clinical Reviews in Allergy & Immunology, 2017, 53 : 452 - 468
  • [2] Medium- and Large-Vessel Vasculitis
    Saadoun, David
    Vautier, Mathieu
    Cacoub, Patrice
    CIRCULATION, 2021, 143 (03) : 267 - 282
  • [3] Pathogenesis of medium- and large-vessel vasculitis
    Weyand, C. M.
    Goronzy, J. J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (02): : 100 - +
  • [4] Kidney involvement in medium- and large-vessel vasculitis
    Federica Maritati
    Francesco Iannuzzella
    Maria P. Pavia
    Sonia Pasquali
    Augusto Vaglio
    Journal of Nephrology, 2016, 29 : 495 - 505
  • [5] Mechanisms of disease: Medium- and large-vessel vasculitis
    Weyand, CM
    Goronzy, JJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02): : 160 - 169
  • [6] Kidney involvement in medium- and large-vessel vasculitis
    Maritati, Federica
    Iannuzzella, Francesco
    Pavia, Maria P.
    Pasquali, Sonia
    Vaglio, Augusto
    JOURNAL OF NEPHROLOGY, 2016, 29 (04) : 495 - 505
  • [7] Medium-vessel and large-vessel vasculitis in children
    Scott, Christiaan
    Stander, Raphaella
    Phoya, Frank
    CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (05) : 278 - 284
  • [8] Immune mechanisms in medium and large-vessel vasculitis
    Cornelia M. Weyand
    Jörg J. Goronzy
    Nature Reviews Rheumatology, 2013, 9 : 731 - 740
  • [9] Immune mechanisms in medium and large-vessel vasculitis
    Weyand, Cornelia M.
    Goronzy, Joerg J.
    NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (12) : 731 - 740
  • [10] Large-vessel vasculitis
    Maksimowicz-McKinnon, K
    Hoffman, GS
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 25 (05) : 569 - 579